Key takeaway: Sagility Limited's investor presentation for Q2 FY27 highlights 11.9% year-over-year constant currency organic revenue growth, driven by expansion in national payers and mid-market clients. The company reported revenue of ₹20,321 million ($212.6M), with adjusted EBITDA of ₹5,353 million ($56.0M) and adjusted PAT of ₹3,254 million ($34.0M). Key developments include winning $40.2M in ACV from 31 existing clients and one new client, with growing AI momentum from new SOW wins and production deployments. Sagility acquired Chirok Health LLC to enhance its provider segment offerings, adding CDI and coding capabilities. The company also noted awards and recognitions, including the Golden Peacock Award for ESG and the Stratus Awards for its SmarTec Nurse Assist solution. Financial metrics show a 22.5% YoY revenue growth, improved adjusted EBITDA margin to 26.3%, and a DSO of 78 days. The presentation also outlines forward-looking positions, including debt repayment plans and amortization schedules for intangible assets. The company reported a steady increase in client base and revenue concentration, with the top 3 clients contributing 60.1% of revenue. Adjusted ROCE remains above 50%, and net debt is at 0.71x. The presentation includes detailed financial statements, balance sheet, and cash flow data for H1 FY27.

Key takeaway: Sagility Limited reported a strong start to FY 2027 during its earnings conference call held on July 21, 2026. Management highlighted a revenue of INR 19,635 million, reflecting a 27.6% year-on-year growth. The growth was attributed to expansion within existing client relationships and strong demand across higher value service lines. Adjusted EBITDA increased by 27.9% year-on-year, with a margin of 24%. Management noted the impact of seasonal revenue normalization and the integration of the CareSeed acquisition, which added 26 new clients. The company emphasized its strategic focus on enhancing service capabilities in the healthcare value chain and expanding into mid- and small-market segments. Management reiterated guidance for low double-digit organic growth in constant currency for FY 2027, despite challenges from minimum wage increases. The call concluded with management expressing confidence in the company's operational resilience and growth potential.

Key takeaway: The investor presentation dated July 21, 2026, reported a 27.3% year-on-year organic growth for Sagility Limited in Q1 FY27, attributed to expansion within existing clients and contributions from new client wins. The company achieved $35.3 million in steady state annual contract value (ACV) during the quarter, driven by opportunities across 18 existing clients and one new client. Sagility acquired CareSeed to enhance its healthcare analytics capabilities, adding 26 new clients. Financial highlights included revenues of ₹19,635 million, adjusted EBITDA of ₹4,716 million, and adjusted PAT of ₹2,697 million, reflecting year-on-year growth rates of 27.6%, 27.9%, and 35.1%, respectively. The presentation also noted the impact of statutory minimum wage increases in Karnataka and Telangana, and recognized Sagility for its workplace culture and contributions to women's organizations. The document emphasized strong cash generation and steady margins.

Key takeaway: Sagility Limited reported strong financial results for Q4 and FY '26 during its earnings call held on May 12, 2026. Management highlighted that FY '26 was an exceptional year, achieving 29.1% revenue growth year-on-year, with Q4 revenues reaching ₹20,243 million ($222.1 million). The company noted a significant increase in seasonal revenues, which accounted for 6% of total revenues compared to 3% in FY '25. Adjusted EBITDA for Q4 was ₹5,036 million, with a margin of 24.9%. For the full year, revenues totaled ₹71,929 million ($814 million), with adjusted PAT rising to ₹11,306 million ($127.9 million), reflecting a 39.5% year-on-year increase. Management discussed the impact of AI on operational efficiency and indicated a goal of low double-digit growth for FY '27, with adjusted EBITDA margins projected between 24% and 25%. The company also announced a final dividend of ₹0.10 per share, subject to shareholder approval.

Key takeaway: The investor presentation from Sagility Limited, dated May 12, 2026, provided an overview of the company's financial performance for the quarter and year ended March 31, 2026. The presentation reported a revenue of ₹20,243 million for Q4 FY26, reflecting a year-on-year growth of 29.1%. Adjusted EBITDA for the same period was ₹5,036 million, with a margin of 24.9%. The company highlighted a 25.8% year-on-year organic growth driven by existing client expansion and new client acquisitions. Sagility onboarded five new clients in Q4 FY26, totaling 17 for the fiscal year. The presentation also noted advancements in AI orchestration through its SmarTec and Synchrony platforms. Additionally, Sagility received recognition as a leader in healthcare payer operations and generative AI services. The document included financial highlights, market trends, and insights into client engagement and operational strategies.

Key takeaway: Sagility Limited submitted an investor presentation on May 12, 2026, detailing its financial results for the quarter and year ended March 31, 2026. The presentation reported a revenue of ₹20,243 million for Q4 FY26, reflecting a year-on-year growth of 29.1%. Adjusted EBITDA for the same period was ₹5,036 million, with a margin of 24.9%. The company highlighted a 25.8% year-on-year organic growth driven by existing client expansion and new client acquisitions. Sagility onboarded five new clients in Q4 FY26, totaling 17 for the fiscal year. The document also noted advancements in AI orchestration through its SmarTec and Synchrony platforms. Additionally, Sagility received recognition as a leader in healthcare payer operations and generative AI services. The presentation included financial highlights, market trends, and insights into client engagement and operational strategies.

Key takeaway: On March 25, 2026, Sagility Limited held an Investor & Analyst Day, where management, including Group CEO Ramesh Gopalan, outlined the company's strategic roadmap and operational capabilities. Management emphasized Sagility's expertise in U.S. healthcare operations, particularly in payer and provider segments, which constitute the majority of their revenue. They reported consistent double-digit growth over the past five years, with EBITDA margins around 24-25%. The discussion highlighted the impact of AI on their operations, with management stating that AI serves as a force multiplier rather than a disruptor. They also addressed challenges in the U.S. healthcare system, including margin compression and membership volatility, while asserting that Sagility's long-term client relationships and operational strength position them well to navigate these changes. The session included a Q&A segment, where management responded to inquiries about AI implementation and its implications for their business model.

Key takeaway: Sagility Limited submitted an investor presentation on March 25, 2026, detailing its operations and growth strategies. The presentation highlighted Sagility's focus on the U.S. healthcare sector, showcasing a robust revenue growth of 14.9% year-over-year, reaching $658.3 million for FY25. Management reported a strong adjusted EBITDA margin of 25.5% for the same period. The company emphasized its extensive service portfolio, which covers the payer value chain, and its capabilities in AI-led solutions. Sagility's operational scale includes over 40,000 healthcare associates across five geographies. The presentation also addressed industry challenges, such as rising medical costs and regulatory complexities, while outlining management's commitment to margin recovery and operational efficiency. The document concluded with a focus on expanding service offerings and client relationships, particularly in small and mid-market segments.

Key takeaway: Sagility Limited held an earnings webinar on January 28, 2026, to discuss its financial results for Q3 FY26. Management reported a consolidated revenue of ₹19,712 million, reflecting a year-on-year growth of 35.7% in INR and 29.1% in constant currency. The Payer segment contributed 90.4% of total revenue, with a growth of 37.3%. Adjusted EBITDA was ₹5,125 million, with a margin of 26%. Management highlighted strong performance in Medicare Advantage programs and projected that open enrollment-related revenues could reach 5.5% of total FY26 revenues. The company aims to expand into mid and small market segments and enhance its managed services offerings. Management also noted ongoing investments in AI and technology to improve operational efficiency. The company increased its revenue growth guidance for FY26 to 22.5% in constant currency, maintaining an adjusted EBITDA margin guidance of 25%.